2,115 press releases in English indexed under biotech & pharma.
Free, virtual meeting on March 16, 2027 will gather patient and care partner testimony on life with MSA to inform future treatments. CHICAGO, Oct. 23, 2026 -- Mission MSA, a nonprofit supporting people affected by multiple system atrophy (MSA), will host a virtual...
NEWTOWN SQUARE, Pa., Oct. 23, 2026 -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that initial safety and efficacy data from the Phase 1 (NCT07066657) study of CDH17-targeted ADC ARR-217 (MRG007) in patients with gastrointestinal cancers, will be presented in a rapid oral presentation at the European Society for Medical Oncology (ESMO) Congress 2026 taking place in Madrid, Spain, on October 23-27, 2026. ArriVent plans to host a virtual webinar on October 26, 2026 at 8 am ET to discuss the data and ARR-217 program. To register for the event, click here.
Collaboration brings Children's Tumor Foundation's deep NF1 expertise and patient and family perspectives into development of GondolaBio's neurofibromatosis type 1 (NF1) program PALO ALTO, Calif. & NEW YORK, October 23, 2026--GondolaBio, a clinical-stage biopharmaceutical company developing novel medic
Clearfork Academy, a youth mental health and rehab center in Texas, has released a guide on involuntary drug and alcohol rehab for teenagers in the state. -- Clearfork Academy has released a guide on involuntary drug and alcohol addiction treatment for teens struggling with substance use disorders in Texas. The guide acknowledges that addicted teens may resist treatment and offers insight into what parents should do
Now with a new route of induction administration, subcutaneous SKYRIZI supports early symptomatic and endoscopic control with an on-body injector...
SERB Pharmaceuticals announces positive results from the Post-Authorisation Efficacy Study (PAES) of Idefirix® (imlifidase),
GLOW Oncology to Host FREE LIVE and Virtual GI and GU Patient Journey Symposium MIAMI BEACH, FL, FL, UNITED STATES, October 23, 2026 / EINPresswire.com / -- Free educational event in Miami Beach will bring patients, caregivers, and healthcare professionals together to explore clinical trials, medical advances, AI in cancer care, nurse navigation, nutrition, and survivorship. Global Leadership in Oncology & Wellness (
The UK’s drug regulatory agency has expanded suicide-risk information to all ages and formally recognizes antidepressant-induced sexual dysfunction The UK’s drug regulatory agency has expanded suicide-risk information to all ages and formally recognizes antidepressant-induced sexual dysfunction
Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to one1 As type 2 diabetes incidence rates among youth continue to rise,² Awiqli® may help reduce administration barriers associated with daily...
Complaint alleges Unicycive Therapeutics, Inc. misled investors between December 29, 2025 and June 29, 2026; investors may seek lead plaintiff role by November 2, 2026 LOS ANGELES, Oct. 23, 2026 -- Glancy Prongay Wolke & Rotter LLP ("Glancy") announced today that the class...
The 1-year graft failure-free survival at 12 months post-transplant was 90%, which is clinically meaningful Graft and patient survival were 92% and 98%, respectively Idefirix was generally well tolerated with a safety profile consistent with previous clinical trial experience LUND,...
The Italian Startups with Consul General Raffaella Valentini The Italian Trade Agency brings a delegation of biotech and life sciences innovators to two of America's leading industry hubs for a 4-week acceleration program SAN DIEGO, CA, UNITED STATES, October 23, 2026 / EINPresswire.com / -- New approaches to overcoming drug resistance in cancer, technologies that accelerate drug discovery, and innovative uses of bio